References
- Global Initiative for chronic obstructive lung disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report. US Department of Health and Human Services. Public Health Service, National Institutes of Health, National Hearth, Lung and Blood Institute. NIH Publication No. 2701; 2001.
- Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997;349:1498–1504.
- Celli BR, Mac Nee W. Standards for the diagnosis and treatment of COPD. Eur Respir J 2002;23:932–46.
- Yang Y, Sun T, Liu X. The role of serum leptin and tumor necrosis factor-α in malnutrition of male chronic obstructive pulmonary disease patients. Chin Med J 2006;119:628–33.
- Bolton CE, Evans M, Lonescu AA, Edwards SM, Morris RH, Dunseath G, Luzio SD, Owens Dr, Shale DJ. Insulin resistance and inflammation. A further systemic complication of COPD. COPD: J Chronic Obstruct Pulmon Dis 2007;4:121–6.
- Engelen MP, Schols AM, Does JD, Wounters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000;71:733–8.
- Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of co-morbidities in newly diagnosed COPD and asthma in primary care. Chest 2005;128:2099–107.
- Wouters EF. Chronic obstructive pulmonary disease: Five systemic effects of COPD. Thorax 2002;57:1067–70.
- Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347–60.
- Lago F, Dieguez C, Gómez-Reino J. Adipokines as emerging mediators of immune response and inflammation. Nature Clin Pract Rheumatol 2007;3:716–24.
- Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003;46:1594–1603.
- Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Taraka M, Kishimato K, Matshuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi K, Akiyoshi M, Ohtsubo T, Kihara S, Yamashito S, Funahashi T, Yamanaka S, Hiramatsy Y, Matsuzawa Y, Shimamura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426–30.
- Liu X, Ji Y, Chen J, Li S, Lou F. Circulating visfatin in chronic obstructive pulmonary disease. Nutrition 2009;25:373–8.
- Lazsio G. Standardization of lung function testing; helpful guidance from the ATS/ERS task force. Thorax 2006;61:744–6.
- ATS Statement: Guidelines for the six-minute walking Test. Am J Respir Crit Care Med 2002;166:111–7.
- Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997;20:1087.
- Takabatake N, Nakamura H, Abe S, Hiro T, Saito H, Yuki H, Kato S, Tomoike H. Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1215–9.
- Gan WQ, Man SFP, Senthilselvan A, Sin DD. Review and a meta-analysis disease and systemic inflammation: a systematic association between chronic obstructive pulmonary disease. Thorax 2004;59;574–80.
- Calikoglu M, Sahin G, Unlu A, Ozturk C, Tamer L, Ercan B, Kanik A, Atik U. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respiration 2004;71:45–50.
- Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Maxham J, Polkey MI. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007;13:8–25.